Histological evaluation of the role of atypical antipsychotic drugs in inducing non-alcoholic fatty liver disease in adult male albino rats (light and electron microscopic study).

Folia Biol (Praha)

Department of Anatomy, Faculty of Medicine, Taibah University, Al Madina Al Monawarrah, Kingdom of Saudi Arabia; Department of Histology and Cell Biology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Published: September 2014

Many of atypical antipsychotic drugs are associated with adverse metabolic effects, including fatty infiltration of the liver. This study aimed at studying the histological evaluation of the role of atypical antipsychotic drugs (olanzapine and aripiprazole) in adult male albino rats. Sixty adult male albino rats were divided equally into three groups. Group I served as a control while groups II and III were treated with olanzapine and aripiprazole consecutively. Sections of the liver were examined by light and electron microscopy. A highly significant increase in the weight of rats in olanzapine- and aripiprazole- treated groups in comparison to the control group was noticed. On the other hand, there was a highly significant increase in body weight of the olanzapine group in comparison to aripiprazole. Olanzapine- and aripiprazole-treated rats showed highly significantly increased fatty infiltration of liver (steatosis) compared with the control group. However, the aripiprazole-treated group showed less steatosis compared with olanzapine. The mean non-alcoholic steatohepatitis scoring and fibrosis of the olanzapine group were highly significantly increased compared to the aripiprazole group. Ultrastructurally, liver from the olanzapine group showed large fat droplets in perinuclear region, between cisternae of the rough endoplasmic reticulum, and in the space of Disse. Large-sized mitochondria and myelin figures were seen. Although histopathological changes of the liver in the form of non-alcoholic fatty liver disease were more prominent in the olanzapine group, they were also evident in the aripiprazole group.

Download full-text PDF

Source

Publication Analysis

Top Keywords

olanzapine group
16
atypical antipsychotic
12
antipsychotic drugs
12
adult male
12
male albino
12
albino rats
12
group
10
histological evaluation
8
evaluation role
8
role atypical
8

Similar Publications

This study aimed to characterize the triple-hit schizophrenia-like model rats (Wisket) by the assessment of (1) behavioral parameters in different test conditions (reward-based Ambitus test and HomeManner system) for a prolonged period, (2) cerebral muscarinic M1 receptor (M1R) expression, and (3) the effects of olanzapine treatment on these parameters. Wistar (control) and Wisket rats were injected for three consecutive weeks with olanzapine depot (100 mg/kg) and spent 4 weeks in large cages with environmental enrichment (HomeManner). The vehicle-treated Wisket rats spent longer time awake with decreased grooming activity compared to controls, without changes in their active social behavior (sniffing, playing, fighting) obtained in HomeManner.

View Article and Find Full Text PDF

Bipolar disorder (BD) frequently occurs in children and adolescents, but pharmacological treatment in this group presents significant challenges. Clinicians often struggle to find appropriate treatment guidelines due to the primary focus of current guidelines on adults, leaving specific recommendations for the acute and maintenance treatment of BD in children and adolescents either insufficient or entirely absent. This gap is partly due to the lack of targeted studies in this age group, leading practitioners to rely on clinical experience and studies conducted in adults.

View Article and Find Full Text PDF

Aim: This study aimed to explore the comparative risks for dystonia among different second-generation antipsychotics (SGAs), the influence of sex, and the relationship between the time-to-onset of dystonia and its outcomes.

Methods: We analyzed data from the Japanese Adverse Drug Event Report database from April 2004 to November 2023. Cases involving oral SGAs, excluding clozapine, were extracted.

View Article and Find Full Text PDF

Background: The use of network pharmacology and blood metabolomics to study the pathogenesis of violent aggression in patients with schizophrenia and the related drug mechanisms of action provides new directions for reducing the risk of violent aggression and optimizing treatment plans.

Aim: To explore the metabolic regulatory mechanism of olanzapine in treating patients with schizophrenia with a moderate to high risk of violent aggression.

Methods: Metabolomic technology was used to screen differentially abundant metabolites in patients with schizophrenia with a moderate to high risk of violent aggression before and after olanzapine treatment, and the related metabolic pathways were identified.

View Article and Find Full Text PDF

Background: Options for 'treatment-resistant bipolar depression' (TRBD) are limited. Two small, short-term, trials of pramipexole suggest it might be an option.

Aims: To evaluate the clinical effectiveness and safety of pramipexole in the management of TRBD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!